Pharmaceutical R&D is focusing on developing ever more specialized drugs, resulting in increasingly more potent APIs. Therefore, the demand for highly potency drug product manufacturing has been steadily increasing over the years and this trend is expected to continue. Is your highly potent strategy efficient and optimal to scale-up?

During this session, you will learn from industry experts about:

• Highly potent drug product challenges and strategies from early development to commercialization
• Small-scale and large-scale equipment (non-GMP)
• Overview of industry standards and beyond
• OEL containment and safeguard of facilities, engineering controls, personnel
• Segregation of manufacturing areas
• Case Studies